To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SEC22BTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
345 supporting clones for gene SEC22B back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BE888831 leiomyosarcoma, uterus SEC22B.a 1 to 745 1 to 754 D13Y T24K C72R Q124R D125M ... tiling clone,   754/869
(86 %)
35 diff
(96.0 %id)
BI762714 pooled colon, kidney, stomach SEC22B.b 1 to 820 1 to 826   tiling clone,   826/908
(90 %)
21 diff
(97.7 %id)
TI_57150762   SEC22B.b 1 to 820 35 to 860       826/942
(87 %)
21 diff
(97.8 %id)
CD697341 normal nasopharynx SEC22B.b 183 to 639 17 to 473       457/473
(96 %)
4 diff
(99.2 %id)
BU860965 mixed (pool of 40 RNAs) SEC22B.b 186 to 946 1 to 768       768/811
(94 %)
24 diff
(97.1 %id)
CD619408   SEC22B.b 188 to 693 31 to 536       506/536
(94 %)
4 diff
(99.3 %id)
NM_004892.4   SEC22B.b 188 to 2008 1 to 1821 exact RefSeq,   1821/1821
(100 %)
1 diff
(100.0 %id)
DB493746 hypothalamus SEC22B.b 191 to 705 1 to 514       514/514
(100 %)
8 diff
(98.5 %id)
BI553276 brain, hippocampus SEC22B.b 192 to 512 1 to 325       325/850
(38 %)
12 diff
(98.6 %id)
AK289875 caudate nucleus SEC22B.b 194 to 1308 1 to 1116 D13Y T24K C72R H132R     1116/1116
(100 %)
10 diff
(99.2 %id)
DA262341 caudate nucleus SEC22B.b 195 to 732 2 to 539   capped   538/538
(100 %)
6 diff
(98.9 %id)
DN998191 breast cancer, Mammary gland (cancer tissue) SEC22B.b 195 to 932 1 to 737       737/738
(99 %)
13 diff
(98.3 %id)
TI_57150534   SEC22B.b 196 to 952 25 to 793       769/835
(92 %)
27 diff
(96.8 %id)
TI_57235334   SEC22B.b 196 to 1010 29 to 840 D13Y T24K F27L A28P Y29T ...     812/844
(96 %)
10 diff
(98.9 %id)
CN286202 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SEC22B.b 198 to 932 1 to 735       735/735
(100 %)
11 diff
(98.6 %id)
BE889761 leiomyosarcoma, uterus SEC22B.b 200 to 958 1 to 766       766/784
(97 %)
32 diff
(96.0 %id)
BI093897 cervix SEC22B.b 201 to 1050 1 to 863 D13Y T24K K43T K44E V45G ...     863/923
(93 %)
39 diff
(95.8 %id)
DR159555 human embryonic stem cells differentiated toan early endodermal cell type SEC22B.b 201 to 994 1 to 793 D13Y T24K C72R H132R     793/793
(100 %)
9 diff
(98.9 %id)
BU194961 melanotic melanoma, skin SEC22B.b 202 to 1032 1 to 842 D13Y T24K C72R Q124P D125G ...     842/890
(94 %)
26 diff
(97.1 %id)
BI762636 pooled colon, kidney, stomach SEC22B.b 203 to 952 1 to 763       763/805
(94 %)
27 diff
(96.7 %id)
BI909259 leukocyte SEC22B.b 203 to 1010 1 to 806 D13Y T24K F27L A28P Y29T ...     806/810
(99 %)
11 diff
(98.7 %id)
BM545350 brain, hippocampus SEC22B.b 203 to 917 27 to 742       716/1151
(62 %)
20 diff
(98.3 %id)
BI917206 brain SEC22B.b 204 to 792 1 to 589       589/590
(99 %)
8 diff
(98.7 %id)
BQ216640 melanotic melanoma, skin SEC22B.b 204 to 785 1 to 583       583/970
(60 %)
11 diff
(98.9 %id)
TI_57242267   SEC22B.b 204 to 792 30 to 618       589/619
(95 %)
8 diff
(98.8 %id)
BG477568 melanotic melanoma, skin SEC22B.b 206 to 907 1 to 703       703/703
(100 %)
9 diff
(98.8 %id)
DB109847 thymus SEC22B.b 208 to 780 2 to 574   capped   573/573
(100 %)
7 diff
(98.8 %id)
BM721629 eye, fetal eye SEC22B.b 209 to 617 1 to 409       409/409
(100 %)
4 diff
(99.1 %id)
AL602308 human skeletal muscle SEC22B.b 214 to 714 1 to 501       501/504
(99 %)
7 diff
(98.7 %id)
BE891299 melanotic melanoma, skin SEC22B.b 217 to 951 1 to 735       735/811
(90 %)
28 diff
(96.6 %id)
AA306105   SEC22B.b 219 to 720 1 to 502       502/503
(99 %)
6 diff
(98.9 %id)
BQ428101 melanotic melanoma, skin SEC22B.b 222 to 991 1 to 775 D13Y T24K C72R L115X S116V ...     775/911
(85 %)
17 diff
(98.2 %id)
BF724863 eye, Iris SEC22B.b 224 to 833 1 to 610       610/610
(100 %)
7 diff
(98.9 %id)
BE275338 melanotic melanoma, skin SEC22B.b 226 to 845 1 to 620       620/648
(95 %)
6 diff
(99.1 %id)
BE728614 melanotic melanoma, skin SEC22B.b 226 to 974 1 to 746       746/750
(99 %)
21 diff
(97.2 %id)
BE276993 melanotic melanoma, skin SEC22B.b 228 to 769 1 to 542       542/542
(100 %)
5 diff
(99.1 %id)
BU161394 melanotic melanoma, skin SEC22B.b 228 to 1098 1 to 876 D13Y T24K C72R H132R L148V     876/879
(99 %)
14 diff
(98.5 %id)
BE541580 cervix SEC22B.b 234 to 820 1 to 590       588/786
(74 %)
29 diff
(96.4 %id)
CN286204 embryonic stem cells, cell lines H1, H7, andH9 SEC22B.b 251 to 915 1 to 665       665/665
(100 %)
7 diff
(99.0 %id)
BM727837 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SEC22B.b 253 to 1003 1 to 748 D13Y T24K C72R A104D L105S ...     748/748
(100 %)
13 diff
(98.3 %id)
BE891858 melanotic melanoma, skin SEC22B.b 256 to 969 1 to 719       719/956
(75 %)
20 diff
(98.0 %id)
BM922769 leukocyte SEC22B.b 256 to 1163 1 to 929 D13Y T24K C72R H132R A140R ...     929/1061
(87 %)
54 diff
(95.0 %id)
BI910309 leukocyte SEC22B.b 260 to 1017 1 to 760 D13Y T24K C72R E96D E97R ...     760/760
(100 %)
25 diff
(96.8 %id)
TI_57236185   SEC22B.b 260 to 1017 31 to 790 D13Y T24K C72R E96D E97R ...     760/790
(96 %)
25 diff
(96.9 %id)
TI_57215788   SEC22B.b 261 to 1054 30 to 824 D13Y T24K C72R V92G A93G ...     795/824
(96 %)
13 diff
(98.5 %id)
TI_57182878   SEC22B.b 261 to 1015 26 to 785 D13Y T24K C72R D109A S110F ...     760/785
(96 %)
13 diff
(98.4 %id)
BG389910 embryonal carcinoma, cell line, testis SEC22B.b 262 to 1029 1 to 773 D13Y T24K C72R K111T A112G ...     773/774
(99 %)
24 diff
(96.9 %id)
AF047442   SEC22B.b 264 to 1697 1 to 1422 D13Y T24K C72R H132R AAA   1422/1422
(100 %)
15 diff
(99.0 %id)
BI754339 brain SEC22B.b 265 to 1054 1 to 791 D13Y T24K C72R V92G A93G ...     791/791
(100 %)
14 diff
(98.3 %id)
BI771489 pooled lung and spleen SEC22B.b 265 to 1015 1 to 756 D13Y T24K C72R D109A S110F ...     756/756
(100 %)
14 diff
(98.2 %id)
BG257912 embryonal carcinoma, cell line, testis SEC22B.b 277 to 983 1 to 703 D13Y T24K C72R Q124R D125M ...     703/1003
(70 %)
20 diff
(98.1 %id)
BM807249 lymph, lymphoma, cell line SEC22B.b 277 to 1304 1 to 1031 D13Y T24K C72R H132R     1031/1031
(100 %)
29 diff
(97.2 %id)
BE891507 melanotic melanoma, skin SEC22B.b 279 to 968 1 to 691       691/691
(100 %)
17 diff
(97.6 %id)
BX282692 epithelioid carcinoma, Pancreas SEC22B.b 284 to 783 1 to 500       500/500
(100 %)
6 diff
(98.8 %id)
BQ433298 epithelioid carcinoma, Pancreas SEC22B.b 285 to 1139 1 to 858 D13Y T24K C72R H132R     858/864
(99 %)
17 diff
(98.1 %id)
DA662453   SEC22B.b 302 to 886 2 to 586   capped   585/585
(100 %)
6 diff
(99.0 %id)
DB119572 thymus SEC22B.b 305 to 848 2 to 545   capped   544/544
(100 %)
6 diff
(98.9 %id)
DA297631 hippocampus SEC22B.b 318 to 893 2 to 577   capped   576/576
(100 %)
7 diff
(98.8 %id)
TI_1948089976   SEC22B.b 322 to 575 120 to 373   fully sequenced,   254/275
(92 %)
3 diff
(99.0 %id)
TI_1948090010   SEC22B.b 322 to 608 124 to 410   fully sequenced,   287/308
(93 %)
3 diff
(99.1 %id)
TI_1948090267   SEC22B.b 322 to 704 120 to 502   fully sequenced,   383/404
(94 %)
3 diff
(99.3 %id)
CV028291 mixed SEC22B.b 328 to 933 1 to 606       606/606
(100 %)
7 diff
(98.9 %id)
TI_1948090131   SEC22B.b 330 to 685 132 to 487   fully sequenced,   356/387
(91 %)
3 diff
(99.3 %id)
AA304969 colon SEC22B.b 349 to 815 1 to 464       464/464
(100 %)
11 diff
(97.7 %id)
AW961186   SEC22B.b 358 to 1016 1 to 659 D13Y T24K C72R H132R A139C ...     659/661
(99 %)
24 diff
(96.4 %id)
AW360911 colon SEC22B.b 377 to 1007 1 to 631 D13Y T24K A28R C72R H132R     631/634
(99 %)
14 diff
(97.8 %id)
AW360937 colon SEC22B.b 377 to 931 1 to 555       553/555
(99 %)
18 diff
(96.8 %id)
AW361006 colon SEC22B.b 397 to 816 1 to 421       421/421
(100 %)
19 diff
(95.5 %id)
DA252280 caudate nucleus SEC22B.b 400 to 975 10 to 585 D13Y T24K C72R H132R capped   576/584
(98 %)
6 diff
(99.0 %id)
CR624978 B cells (Ramos cell line) Cot 25-normalized SEC22B.b 400 to 2008 1 to 1609 exact tiling clone,   1609/1609
(100 %)
0 diff
(100 %id)
BX334197 Neuroblastoma Cot 50-normalized SEC22B.b 400 to 1002 1 to 603 D13Y T24K C72R H132R     603/603
(100 %)
8 diff
(98.7 %id)
BX438985 placenta SEC22B.b 400 to 1248 1 to 838 D13Y T24K C72R H132R     838/853
(98 %)
29 diff
(96.7 %id)
BX441057 brain, fetal brain SEC22B.b 400 to 922 1 to 532       532/536
(99 %)
21 diff
(96.1 %id)
BX399360 Placenta Cot 25-normalized SEC22B.b 400 to 1246 1 to 842 D13Y T24K P51X Y52X I55X ...     842/858
(98 %)
23 diff
(97.4 %id)
BX399788 Placenta Cot 25-normalized SEC22B.b 400 to 1226 1 to 825 D13Y T24K C72S N113X H132R     825/825
(100 %)
20 diff
(97.6 %id)
BX363510   SEC22B.b 400 to 1276 1 to 868 D13Y T24K C72R H132R     868/961
(90 %)
28 diff
(97.1 %id)
DA650003   SEC22B.b 400 to 935 10 to 549   capped   540/548
(98 %)
11 diff
(98.0 %id)
DA816437   SEC22B.b 400 to 954 10 to 564   capped   555/563
(98 %)
6 diff
(99.0 %id)
BX339506 Placenta Cot 25-normalized SEC22B.b 401 to 1276 1 to 873 D13Y T24K C72R H132R     873/891
(97 %)
28 diff
(96.9 %id)
BU945567 mixed (pool of 40 RNAs) SEC22B.b 432 to 1231 1 to 805 D13Y T24K C72R H132R     805/813
(99 %)
21 diff
(97.5 %id)
DA648534   SEC22B.b 450 to 928 2 to 480   capped   479/479
(100 %)
7 diff
(98.6 %id)
DB013070 esophageal, tumor tissue SEC22B.b 474 to 1037 2 to 565 D13Y A19V T24K C72R H132R capped   564/564
(100 %)
8 diff
(98.6 %id)
TI_1948090394   SEC22B.b 490 to 974 609 to 125       485/512
(94 %)
5 diff
(99.1 %id)
BX384476   SEC22B.b 510 to 1402 1 to 889       889/890
(99 %)
21 diff
(97.7 %id)
DA113570 cerebellum SEC22B.b 512 to 964 121 to 573   capped   453/572
(79 %)
3 diff
(99.5 %id)
DA120146 cerebellum SEC22B.b 512 to 926 123 to 537   capped   415/536
(77 %)
3 diff
(99.5 %id)
AW363228 colon SEC22B.b 513 to 907 72 to 468       397/468
(84 %)
19 diff
(96.0 %id)
TI_1948089977   SEC22B.b 545 to 974 554 to 125   fully sequenced,   430/457
(94 %)
4 diff
(99.2 %id)
AW993268 breast_normal SEC22B.b 568 to 1261 705 to 13     Submitted on the opposite strand 693/706
(98 %)
8 diff
(98.9 %id)
AW993471 breast_normal SEC22B.b 570 to 1265 1 to 698       698/698
(100 %)
10 diff
(98.6 %id)
BP264657 umbilical vein SEC22B.b 570 to 1144 1 to 575       575/575
(100 %)
9 diff
(98.5 %id)
AW993481 breast_normal SEC22B.b 575 to 1261 11 to 691       681/694
(98 %)
11 diff
(98.5 %id)
TI_1948090011   SEC22B.b 578 to 974 524 to 128   fully sequenced,   397/424
(93 %)
3 diff
(99.3 %id)
AW993283 breast_normal SEC22B.b 591 to 1233 647 to 7     Submitted on the opposite strand 641/647
(99 %)
5 diff
(99.3 %id)
BF816488 colon_ins SEC22B.b 602 to 1013 414 to 3     Submitted on the opposite strand 412/416
(99 %)
3 diff
(99.3 %id)
AW993201 breast_normal SEC22B.b 607 to 1243 643 to 1     Submitted on the opposite strand 643/643
(100 %)
29 diff
(95.5 %id)
AW992919 breast_normal SEC22B.b 619 to 1244 640 to 14     Submitted on the opposite strand 627/641
(97 %)
3 diff
(99.6 %id)
AW993467 breast_normal SEC22B.b 622 to 1262 658 to 19     Submitted on the opposite strand 640/658
(97 %)
6 diff
(99.1 %id)
AW992921 breast_normal SEC22B.b 632 to 1246 624 to 9     Submitted on the opposite strand 616/624
(98 %)
5 diff
(99.2 %id)
AW992861 breast_normal SEC22B.b 633 to 1241 616 to 7     Submitted on the opposite strand 610/616
(99 %)
4 diff
(99.4 %id)
TI_1948090132   SEC22B.b 643 to 974 455 to 124   fully sequenced,   332/359
(92 %)
3 diff
(99.2 %id)
TI_1948090268   SEC22B.b 643 to 974 456 to 125   fully sequenced,   332/359
(92 %)
3 diff
(99.2 %id)
BP198899 brain SEC22B.b 653 to 1237 1 to 585       585/585
(100 %)
6 diff
(99.0 %id)
BP260918 small intestine SEC22B.b 670 to 1244 1 to 577       577/577
(100 %)
11 diff
(98.1 %id)
AW992980 breast_normal SEC22B.b 678 to 1296 618 to 2     Submitted on the opposite strand 617/618
(99 %)
3 diff
(99.6 %id)
AW993220 breast_normal SEC22B.b 680 to 1266 8 to 593       586/594
(98 %)
8 diff
(98.7 %id)
BP350772   SEC22B.b 694 to 1274 1 to 582       582/582
(100 %)
6 diff
(99.0 %id)
AU310163 neuroblastoma SEC22B.b 696 to 1256 14 to 575       562/562
(100 %)
6 diff
(99.0 %id)
AW579514 head_neck SEC22B.b 713 to 1210 18 to 515       498/515
(96 %)
3 diff
(99.5 %id)
BP332191 renal proximal tubule SEC22B.b 713 to 1286 1 to 578       578/582
(99 %)
13 diff
(97.8 %id)
EL950394 eyeball SEC22B.b 720 to 1163 1 to 442       442/442
(100 %)
11 diff
(97.6 %id)
AW993460 breast_normal SEC22B.b 738 to 1230 500 to 5     Submitted on the opposite strand 496/500
(99 %)
6 diff
(98.8 %id)
EL947137 eyeball SEC22B.b 742 to 1262 1 to 522       522/522
(100 %)
8 diff
(98.5 %id)
BG192192   SEC22B.b 826 to 1612 9 to 793       785/793
(98 %)
0 diff
(100 %id)
BX487780   SEC22B.b 834 to 1380 1 to 548       548/548
(100 %)
3 diff
(99.5 %id)
BP277566 Kidney SEC22B.b 841 to 1285 1 to 446       446/580
(76 %)
13 diff
(97.8 %id)
DA134928 alzheimer cortex SEC22B.b 844 to 1396 2 to 556   capped   555/561
(98 %)
6 diff
(99.0 %id)
DA880749   SEC22B.b 847 to 1385 2 to 541   capped   540/541
(99 %)
4 diff
(99.3 %id)
BU571150 brain, glioblastoma SEC22B.b 863 to 1711 1 to 852       852/852
(100 %)
60 diff
(93.0 %id)
BF690915 melanotic melanoma, high MDR, skin SEC22B.b 882 to 1386 1 to 506       506/616
(82 %)
7 diff
(98.9 %id)
FN108912 breast carcinoma SEC22B.b 897 to 956 59 to 1     Submitted on the opposite strand 59/60
(98 %)
1 diff
(98.4 %id)
BG573124 placenta SEC22B.b 913 to 1396 1 to 485       485/488
(99 %)
4 diff
(99.2 %id)
BX106423 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SEC22B.b 935 to 1309 1 to 380       380/380
(100 %)
6 diff
(98.5 %id)
CR737100   SEC22B.b 935 to 1409 1 to 475       475/477
(99 %)
5 diff
(99.0 %id)
AA234796 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SEC22B.b 935 to 1371 1 to 438       438/438
(100 %)
2 diff
(99.6 %id)
AA456385 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SEC22B.b 935 to 1393 1 to 461       461/461
(100 %)
3 diff
(99.4 %id)
BE842996 stomach SEC22B.b 967 to 1127 166 to 9       158/167
(94 %)
14 diff
(91.7 %id)
AI902726 breast SEC22B.b 973 to 1326 1 to 355       355/355
(100 %)
3 diff
(99.2 %id)
BG426048 Kidney SEC22B.b 1004 to 1404 1 to 405       405/874
(46 %)
10 diff
(98.9 %id)
BE090999 breast SEC22B.b 1022 to 1352 28 to 357       330/366
(90 %)
6 diff
(98.4 %id)
AA354813   SEC22B.b 1028 to 1337 1 to 314       314/314
(100 %)
5 diff
(98.5 %id)
BX328171   SEC22B.b 1061 to 1909 1 to 853   AAA   853/958
(89 %)
29 diff
(97.0 %id)
FN158531 breast carcinoma SEC22B.b 1088 to 1201 1 to 116       116/116
(100 %)
3 diff
(97.5 %id)
FN119339 breast carcinoma SEC22B.b 1128 to 1187 60 to 1     Submitted on the opposite strand 60/60
(100 %)
1 diff
(98.4 %id)
FN160518 breast carcinoma SEC22B.b 1145 to 1257 1 to 116       116/118
(98 %)
9 diff
(92.4 %id)
EC473759 Prostate SEC22B.b 1173 to 1287 1 to 116       116/116
(100 %)
1 diff
(99.2 %id)
CD104894 Pooled-Skin SEC22B.b 1210 to 1966 1 to 751       751/774
(97 %)
11 diff
(98.6 %id)
FN063941 breast carcinoma SEC22B.b 1234 to 1295 61 to 1     Submitted on the opposite strand 61/62
(98 %)
1 diff
(98.4 %id)
AA135767 uterus SEC22B.b 1246 to 1721 1 to 470       470/491
(95 %)
8 diff
(98.4 %id)
FN084166 breast carcinoma SEC22B.b 1289 to 1375 88 to 4     Submitted on the opposite strand 85/91
(93 %)
0 diff
(100 %id)
BQ344763 nervous_tumor SEC22B.b 1306 to 1421 1 to 117       117/138
(84 %)
6 diff
(95.7 %id)
AW245633 lung, small cell carcinoma SEC22B.b 1397 to 1672 285 to 11   AAA   572/572
(100 %)
10 diff
(98.3 %id)
BM836953 Ascites, stomach SEC22B.b 1397 to 1518 430 to 551       551/551
(100 %)
13 diff
(97.7 %id)
TI_154035306   SEC22B.b 1397 to 1715 407 to 90   AAA   800/941
(85 %)
19 diff
(98.0 %id)
BU741516 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SEC22B.b 1397 to 2012 633 to 19   AAA   677/677
(100 %)
8 diff
(98.9 %id)
CA443902 Fibrosarcoma SEC22B.b 1397 to 1715 336 to 19   AAA   615/615
(100 %)
9 diff
(98.6 %id)
CA418993 Chondrosarcoma Grade II, Left Pelvis SEC22B.b 1397 to 1672 294 to 19   AAA   747/747
(100 %)
9 diff
(98.8 %id)
AI425113 pooled SEC22B.b 1399 to 1710 323 to 12   AAA   312/312
(100 %)
4 diff
(98.8 %id)
AI425056 pooled SEC22B.b 1399 to 1710 323 to 12   AAA   312/312
(100 %)
3 diff
(99.1 %id)
AA613384 colon, colon tumor RER+ SEC22B.b 1404 to 1674 270 to 1       287/287
(100 %)
10 diff
(96.6 %id)
CN479119 Human Lung Epithelial cells, lung SEC22B.b 1404 to 1939 1 to 537     Submitted on the opposite strand 537/537
(100 %)
12 diff
(97.8 %id)
DA235320 brain SEC22B.b 1409 to 1464 532 to 586   capped   585/585
(100 %)
4 diff
(99.4 %id)
BX366387 Neuroblastoma Cot 25-normalized SEC22B.b 1409 to 1676 130 to 394       394/395
(99 %)
7 diff
(98.3 %id)
AI219969 pooled SEC22B.b 1409 to 1710 313 to 12   AAA   362/362
(100 %)
8 diff
(97.8 %id)
AI356111 anaplastic oligodendroglioma, brain SEC22B.b 1409 to 1672 287 to 24   AAA   324/324
(100 %)
12 diff
(96.3 %id)
CB988823 Human Placenta, placenta SEC22B.b 1409 to 1632 470 to 697       679/832
(81 %)
25 diff
(97.0 %id)
BQ018742 lung, Metastatic Chondrosarcoma SEC22B.b 1411 to 2012 617 to 19   AAA   696/696
(100 %)
5 diff
(99.3 %id)
DA809421 brain SEC22B.b 1411 to 1948 56 to 592   capped   591/591
(100 %)
6 diff
(99.0 %id)
BQ573950 Chondrosarcoma Grade II, Left Pelvis SEC22B.b 1411 to 1672 277 to 19   AAA   361/361
(100 %)
5 diff
(98.7 %id)
BX366388 Neuroblastoma Cot 25-normalized SEC22B.b 1412 to 1664 133 to 383   AAA   383/383
(100 %)
15 diff
(96.1 %id)
CA424943 cell lines, Chondrosarcoma SEC22B.b 1412 to 1672 277 to 19   AAA   571/571
(100 %)
5 diff
(99.2 %id)
AV742150 cord Blood SEC22B.b 1414 to 1496 89 to 7     Submitted on the opposite strand 83/96
(86 %)
0 diff
(100 %id)
GD147590   SEC22B.b 1414 to 1803 395 to 6   AAA Submitted on the opposite strand 390/397
(98 %)
0 diff
(100 %id)
AA455917 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SEC22B.b 1414 to 1712 299 to 1       299/305
(98 %)
1 diff
(99.7 %id)
AA890010 parathyroid gland, parathyroid tumor SEC22B.b 1414 to 1904 1 to 491     Submitted on the opposite strand 491/491
(100 %)
3 diff
(99.4 %id)
AI003990   SEC22B.b 1414 to 1881 1 to 468     Submitted on the opposite strand 468/468
(100 %)
4 diff
(99.2 %id)
AI031777 parathyroid gland, parathyroid tumor SEC22B.b 1415 to 1855 1 to 441     Submitted on the opposite strand 441/441
(100 %)
4 diff
(99.1 %id)
AI026160 parathyroid gland, parathyroid tumor SEC22B.b 1416 to 1669 1 to 254     Submitted on the opposite strand 254/254
(100 %)
2 diff
(99.3 %id)
AI369493   SEC22B.b 1416 to 1710 1 to 295     Submitted on the opposite strand 295/295
(100 %)
2 diff
(99.4 %id)
AW958448   SEC22B.b 1417 to 1675 370 to 626       626/628
(99 %)
13 diff
(98.0 %id)
AA960876 pooled SEC22B.b 1417 to 1828 1 to 412     Submitted on the opposite strand 412/412
(100 %)
2 diff
(99.6 %id)
AI472186 pooled SEC22B.b 1417 to 1791 1 to 376     Submitted on the opposite strand 376/376
(100 %)
3 diff
(99.3 %id)
AA911416 carcinoid, lung SEC22B.b 1419 to 1637 1 to 219     Submitted on the opposite strand 219/219
(100 %)
2 diff
(99.1 %id)
AI333053 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SEC22B.b 1419 to 1869 1 to 451     Submitted on the opposite strand 451/451
(100 %)
2 diff
(99.6 %id)
FN080743 breast carcinoma SEC22B.b 1420 to 1503 84 to 1     Submitted on the opposite strand 84/84
(100 %)
0 diff
(100 %id)
FN051800 breast carcinoma SEC22B.b 1421 to 1524 1 to 104       104/104
(100 %)
3 diff
(97.2 %id)
N78994 parathyroid gland, parathyroid tumor SEC22B.b 1421 to 1607 1 to 187     Submitted on the opposite strand 187/187
(100 %)
2 diff
(99.0 %id)
AA437375 ovarian tumor, ovary SEC22B.b 1421 to 1832 1 to 412     Submitted on the opposite strand 412/412
(100 %)
2 diff
(99.6 %id)
AI472262 pooled SEC22B.b 1421 to 1887 1 to 467     Submitted on the opposite strand 467/467
(100 %)
3 diff
(99.4 %id)
BF693195 muscle (skeletal) SEC22B.b 1421 to 1989 1 to 574       574/661
(86 %)
37 diff
(94.5 %id)
CD619407   SEC22B.b 1422 to 1532 131 to 21       111/131
(84 %)
0 diff
(100 %id)
AA255500 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SEC22B.b 1422 to 1772 1 to 351     Submitted on the opposite strand 351/351
(100 %)
3 diff
(99.2 %id)
AA412352   SEC22B.b 1422 to 1789 1 to 368     Submitted on the opposite strand 368/368
(100 %)
3 diff
(99.2 %id)
AA829708 carcinoid, lung SEC22B.b 1423 to 1839 1 to 417     Submitted on the opposite strand 417/417
(100 %)
2 diff
(99.6 %id)
AA426574   SEC22B.b 1424 to 1831 1 to 407     Submitted on the opposite strand 407/407
(100 %)
3 diff
(99.3 %id)
BX392946 Placenta Cot 25-normalized SEC22B.b 1432 to 2013 1 to 582     Submitted on the opposite strand 582/582
(100 %)
16 diff
(97.3 %id)
BX392423 Neuroblastoma Cot 50-normalized SEC22B.b 1434 to 1978 1 to 550     Submitted on the opposite strand 550/559
(98 %)
38 diff
(93.3 %id)
BQ719526 sympathetic trunk SEC22B.b 1438 to 1942 37 to 552       516/1079
(47 %)
28 diff
(97.5 %id)
BI260001 cervical carcinoma cell line, cervix SEC22B.b 1448 to 2008 1 to 562   AAA   562/562
(100 %)
5 diff
(99.2 %id)
AA418939 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SEC22B.b 1452 to 1635 1 to 184       184/184
(100 %)
1 diff
(99.5 %id)
AA150809 uterus SEC22B.b 1456 to 1853 1 to 401       401/402
(99 %)
6 diff
(98.6 %id)
AV749060 Pituitary SEC22B.b 1460 to 1735 1 to 277       277/277
(100 %)
11 diff
(96.1 %id)
BG435520 placenta SEC22B.b 1465 to 1898 1 to 435       435/436
(99 %)
12 diff
(97.3 %id)
R80136 placenta SEC22B.b 1466 to 1860 1 to 408       408/410
(99 %)
18 diff
(95.7 %id)
AA484677 alveolar rhabdomyosarcoma SEC22B.b 1524 to 1676 172 to 20       153/172
(88 %)
0 diff
(100 %id)
FN155523 breast carcinoma SEC22B.b 1531 to 1645 113 to 2     Submitted on the opposite strand 112/113
(99 %)
0 diff
(100 %id)
C21514   SEC22B.b 1536 to 1672 1 to 137       137/137
(100 %)
0 diff
(100 %id)
R64199 placenta SEC22B.b 1541 to 2008 476 to 1     Submitted on the opposite strand 476/479
(99 %)
31 diff
(93.6 %id)
FN056832 breast carcinoma SEC22B.b 1615 to 1738 124 to 1     Submitted on the opposite strand 124/124
(100 %)
0 diff
(100 %id)
AA042834 uterus SEC22B.b 1625 to 1807 1 to 183       183/183
(100 %)
1 diff
(99.5 %id)
FN173910 breast carcinoma SEC22B.b 1639 to 1763 120 to 1     Submitted on the opposite strand 120/120
(100 %)
5 diff
(95.9 %id)
FN140570 breast carcinoma SEC22B.b 1671 to 1790 1 to 121       121/121
(100 %)
5 diff
(95.9 %id)
BM677235 eye, fetal eye SEC22B.b 1794 to 2210 435 to 19   tiling clone, AAA   417/421
(99 %)
4 diff
(99.1 %id)
CN286203 embryonic stem cells, DMSO-treated H9 cellline SEC22B.c 1 to 458 1 to 458   tiling clone,   458/458
(100 %)
8 diff
(98.3 %id)
BM153818 leukopheresis SEC22B.c 8 to 115 1 to 108       108/108
(100 %)
2 diff
(98.2 %id)
BM152505 leukopheresis SEC22B.c 8 to 315 1 to 307   tiling clone,   307/307
(100 %)
4 diff
(98.7 %id)
AV739328 cord Blood SEC22B.c 42 to 287 44 to 286       243/310
(78 %)
4 diff
(98.8 %id)
CN286201 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SEC22B.c 83 to 785 1 to 704 D13Y T24K C72R S120T tiling clone,   704/704
(100 %)
10 diff
(98.6 %id)
BF359626 marrow SEC22B.c 90 to 314 1 to 225       225/225
(100 %)
10 diff
(95.6 %id)
FN134342 breast carcinoma SEC22B.c 112 to 170 57 to 1     Submitted on the opposite strand 57/57
(100 %)
2 diff
(96.5 %id)
BF951484 nervous_normal SEC22B.c 138 to 279 19 to 157       139/158
(87 %)
6 diff
(96.3 %id)
BX499235 Liver SEC22B.c 481 to 1035 1 to 554   tiling clone,   554/554
(100 %)
31 diff
(94.5 %id)
AK023270   SEC22B.c 617 to 2710 1 to 2094   tiling clone, available from FLJ,   2094/2094
(100 %)
9 diff
(99.6 %id)
AU132625   SEC22B.c 618 to 1484 2 to 865   capped   864/864
(100 %)
11 diff
(98.8 %id)
DB218582 trachea SEC22B.c 1086 to 1648 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
AA323117 brain, cerebellum SEC22B.c 1159 to 1373 1 to 216       216/216
(100 %)
3 diff
(98.7 %id)
DB216452 trachea SEC22B.c 1296 to 1808 2 to 514   capped   513/513
(100 %)
2 diff
(99.7 %id)
ES308798 beard hair, skin SEC22B.c 1452 to 1616 10 to 174       165/174
(94 %)
0 diff
(100 %id)
DB144698 thymus SEC22B.c 2184 to 2734 2 to 552   tiling clone, capped   551/551
(100 %)
3 diff
(99.5 %id)
AU154125   SEC22B.c 2189 to 2710 521 to 1       521/522
(99 %)
4 diff
(99.3 %id)
BE644694 carcinoid, lung SEC22B.c 2346 to 2710 384 to 20   AAA   365/365
(100 %)
5 diff
(98.7 %id)
DA256295 caudate nucleus SEC22B.d 1 to 305 249 to 553   tiling clone, capped   305/552
(55 %)
7 diff
(98.8 %id)
BP229923 brain SEC22B.d 1 to 498 91 to 588 D13Y T24K K63I C72R R74L ... tiling clone,   498/588
(84 %)
18 diff
(97.0 %id)
FN099431 breast carcinoma SEC22B.d 183 to 292 1 to 111       111/111
(100 %)
3 diff
(97.3 %id)
DA568435 whole embryo, mainly head SEC22B.e-u 1 to 806 2 to 798 R27H L39F tiling clone, capped   797/797
(100 %)
17 diff
(97.9 %id)
BU930530 Prostate SEC22B.e-u 89 to 846 30 to 793 R27H H34R N35H L37X L39I ... tiling clone,   764/794
(96 %)
25 diff
(96.9 %id)
BM729058 eye, fetal eye SEC22B.e-u 92 to 591 36 to 536       501/536
(93 %)
6 diff
(98.9 %id)
BM978624 lung, Primary Lung Epithelial Cells SEC22B.e-u 96 to 833 1 to 738 R27H L39F tiling clone, Submitted on the opposite strand 738/738
(100 %)
9 diff
(98.8 %id)
BX330616 Placenta Cot 25-normalized SEC22B.e-u 132 to 914 1 to 787 R2H T3E K4N A5I P7R ...   Submitted on the opposite strand 787/923
(85 %)
68 diff
(92.7 %id)
BX331098   SEC22B.e-u 160 to 700 28 to 566 L18V R27H S32F H34P N35I ...   Submitted on the opposite strand 539/566
(95 %)
6 diff
(99.0 %id)
R65855 placenta SEC22B.e-u 164 to 452 1 to 294   fully sequenced,   294/294
(100 %)
3 diff
(99.0 %id)
H00525 placenta SEC22B.e-u 164 to 414 1 to 258   fully sequenced,   258/258
(100 %)
3 diff
(98.9 %id)
BP290415 lung SEC22B.e-u 172 to 750 1 to 580 R27H L39F     580/580
(100 %)
16 diff
(97.3 %id)
AW073533 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma SEC22B.e-u 187 to 680 495 to 1 R27H L39F     495/495
(100 %)
8 diff
(98.4 %id)
W23469 parathyroid gland, parathyroid tumor SEC22B.e-u 198 to 715 1 to 523 R27H C33W H34P N35Q L36F ...     523/523
(100 %)
15 diff
(97.2 %id)
BG778400 adenocarcinoma, Prostate SEC22B.e-u 242 to 855 1 to 613 R27H L39F     613/613
(100 %)
11 diff
(98.3 %id)
BM557201 melanotic melanoma, skin SEC22B.e-u 256 to 736 497 to 18 R27H L39F   Submitted on the opposite strand 480/575
(83 %)
0 diff
(100 %id)
BU508124 leiomyosarcoma, uterus SEC22B.e-u 278 to 1251 1 to 983 R27H L39F     983/1132
(86 %)
11 diff
(99.1 %id)
BX424425 placenta SEC22B.e-u 284 to 1162 1 to 875 R27H L39F     875/875
(100 %)
11 diff
(98.8 %id)
BX458973 placenta SEC22B.e-u 284 to 1144 1 to 852 T3R A5G P7X Y11X L14X ...     852/861
(98 %)
91 diff
(89.5 %id)
AI085383 senescent fibroblast SEC22B.e-u 298 to 775 486 to 9 R27H L39F     478/486
(98 %)
4 diff
(99.2 %id)
AI267455 brain, frontal lobe (see description) SEC22B.e-u 298 to 772 506 to 32 R27H L39F     475/506
(93 %)
0 diff
(100 %id)
BG007325 placenta_normal SEC22B.e-u 304 to 845 541 to 1 R27H L39F tiling clone,   541/541
(100 %)
6 diff
(98.9 %id)
AI160782 placenta SEC22B.e-u 319 to 710 392 to 1 R27H L39F     392/392
(100 %)
3 diff
(99.3 %id)
BI092644 cervix SEC22B.e-u 322 to 1151 1 to 829 R27H L39F     829/840
(98 %)
11 diff
(98.7 %id)
BF573114 melanotic melanoma, high MDR, skin SEC22B.e-u 324 to 929 1 to 613 R27H S31P S32L C33A N35K ...     613/869
(70 %)
37 diff
(95.8 %id)
BQ429128 testis SEC22B.e-u 342 to 1113 1 to 771 R27H L39F     771/771
(100 %)
20 diff
(97.5 %id)
AW471089 colon, moderately-differentiated adenocarcinoma SEC22B.e-u 346 to 708 363 to 1 R27H L39F     363/363
(100 %)
3 diff
(99.2 %id)
AW165953 brain, medulloblastoma SEC22B.e-u 349 to 772 425 to 2 exact tiling clone,   424/425
(99 %)
0 diff
(100 %id)
AA434006 ovarian tumor, ovary SEC22B.e-u 352 to 681 330 to 1 R27H L39F   Submitted on the opposite strand 330/330
(100 %)
3 diff
(99.1 %id)
AA902153 pooled germ cell tumors SEC22B.e-u 364 to 767 403 to 1 R27H L39F     403/403
(100 %)
5 diff
(98.8 %id)
BP418290 small intestine SEC22B.e-u 365 to 852 1 to 499 R27H L39F   Submitted on the opposite strand 499/500
(99 %)
23 diff
(95.4 %id)
BF213200 bone marrow, from acute myelogenous leukemia SEC22B.e-u 376 to 930 1 to 538 R27H L29C S31P S32L C33A ...     538/858
(62 %)
12 diff
(98.7 %id)
H00471 placenta SEC22B.e-u 384 to 675 300 to 1 R27H L39F fully sequenced,   300/300
(100 %)
4 diff
(98.7 %id)
AI587034 adenocarcinoma, Pancreas SEC22B.e-u 420 to 767 375 to 28 L21F S24R L26F R27P C28W ... AAA   348/348
(100 %)
25 diff
(92.9 %id)
R65766 placenta SEC22B.e-u 422 to 707 293 to 4 G8R Y9L N10* fully sequenced,   290/293
(98 %)
9 diff
(97.0 %id)
AA902160 pooled germ cell tumors SEC22B.e-u 436 to 767 331 to 1 R27H L39F     331/331
(100 %)
5 diff
(98.5 %id)
CB987075 Pooled-Glandular SEC22B.e-u 447 to 1021 1 to 580 R27H L39F tiling clone,   580/818
(70 %)
14 diff
(98.3 %id)
DW438962 Liver SEC22B.e-u 449 to 675 17 to 243 R27H L39F     227/243
(93 %)
6 diff
(97.6 %id)
AW805344 uterus SEC22B.e-u 450 to 599 160 to 11       150/160
(93 %)
0 diff
(100 %id)
AA256706 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SEC22B.e-u 453 to 697 245 to 1 R27H L39F   Submitted on the opposite strand 245/245
(100 %)
3 diff
(98.8 %id)
BF089762 head_neck SEC22B.e-u 455 to 607 1 to 152       152/154
(98 %)
8 diff
(94.9 %id)
BG002557 placenta_normal SEC22B.e-u 473 to 652 6 to 181 R27H L29C S31P S32L C33A ...     176/182
(96 %)
17 diff
(90.7 %id)
EC515256 Prostate SEC22B.e-u 476 to 586 1 to 110       110/111
(99 %)
3 diff
(97.3 %id)
W20255 parathyroid gland, parathyroid tumor SEC22B.e-u 487 to 641 160 to 6 R2X R27H L39F   Submitted on the opposite strand 155/160
(96 %)
0 diff
(100 %id)
EH331516   SEC22B.e-u 496 to 568 1 to 73       73/73
(100 %)
0 diff
(100 %id)
FN095806 breast carcinoma SEC22B.e-u 514 to 637 121 to 1     Submitted on the opposite strand 121/121
(100 %)
5 diff
(95.9 %id)
DA327867 hippocampus SEC22B.e-u 528 to 1094 2 to 565   capped   564/564
(100 %)
9 diff
(98.5 %id)
DB224825 trachea SEC22B.e-u 534 to 858 2 to 326   capped   325/325
(100 %)
3 diff
(99.1 %id)
CB984410 Pooled-Glandular SEC22B.e-u 581 to 1322 1 to 754       754/766
(98 %)
22 diff
(97.2 %id)
FN071724 breast carcinoma SEC22B.e-u 583 to 673 1 to 88       88/88
(100 %)
4 diff
(95.5 %id)
AA383100 testis SEC22B.e-u 589 to 860 1 to 273       273/273
(100 %)
4 diff
(98.6 %id)
C04925 heart SEC22B.e-u 599 to 930 1 to 332   tiling clone,   332/380
(87 %)
3 diff
(99.3 %id)
BM748964 Ascites, stomach SEC22B.e-u 606 to 930 1 to 325       325/336
(96 %)
4 diff
(98.9 %id)
BX434306 placenta SEC22B.e-u 638 to 1495 861 to 4   tiling clone,   858/861
(99 %)
0 diff
(100 %id)
BQ376024 testis_normal SEC22B.e-u 643 to 1054 64 to 472       409/478
(85 %)
21 diff
(95.7 %id)
EC448964 Prostate SEC22B.e-u 645 to 762 115 to 1       115/115
(100 %)
4 diff
(96.6 %id)
EC549858 Prostate SEC22B.e-u 645 to 762 114 to 1       114/114
(100 %)
7 diff
(93.9 %id)
BM801024 melanotic melanoma, skin SEC22B.e-u 659 to 1517 903 to 34   tiling clone, Submitted on the opposite strand 870/1065
(81 %)
0 diff
(100 %id)
BF570951 melanotic melanoma, high MDR, skin SEC22B.e-u 662 to 1316 1 to 664       664/1348
(49 %)
25 diff
(98.2 %id)
BF571707 melanotic melanoma, high MDR, skin SEC22B.e-u 662 to 1347 1 to 681       681/768
(88 %)
16 diff
(98.0 %id)
BF572421 melanotic melanoma, high MDR, skin SEC22B.e-u 662 to 1333 1 to 667       667/746
(89 %)
58 diff
(92.3 %id)
BF977632 melanotic melanoma, high MDR, skin SEC22B.e-u 662 to 1430 1 to 748       748/800
(93 %)
29 diff
(96.4 %id)
BF979193 melanotic melanoma, high MDR, skin SEC22B.e-u 662 to 1347 1 to 674       674/873
(77 %)
14 diff
(98.4 %id)
BF978864 melanotic melanoma, high MDR, skin SEC22B.e-u 662 to 1402 1 to 729       729/876
(83 %)
61 diff
(93.1 %id)
BF691500 melanotic melanoma, high MDR, skin SEC22B.e-u 662 to 1122 1 to 467       467/467
(100 %)
15 diff
(96.8 %id)
BF692667 melanotic melanoma, high MDR, skin SEC22B.e-u 662 to 1359 1 to 686       686/1007
(68 %)
8 diff
(99.3 %id)
EC559322 Prostate SEC22B.e-u 681 to 771 96 to 5       92/104
(88 %)
0 diff
(100 %id)
BM873847   SEC22B.e-u 684 to 1115 1 to 428       428/428
(100 %)
6 diff
(98.6 %id)
CB962775 Blood vessels - aorta, basilar and artery SEC22B.e-u 694 to 1092 1 to 395   AAA   395/395
(100 %)
8 diff
(98.0 %id)
TI_149313269   SEC22B.e-u 714 to 1516 915 to 128   AAA   788/954
(82 %)
19 diff
(98.1 %id)
AV703649 adrenal gland SEC22B.e-u 752 to 1372 1 to 617       617/666
(92 %)
7 diff
(99.0 %id)
BG119454 adenocarcinoma, cell line, Liver SEC22B.e-u 782 to 1516 722 to 1     Submitted on the opposite strand 722/956
(75 %)
12 diff
(98.8 %id)
BQ006596 Chondrosarcoma, Left Pelvis SEC22B.e-u 785 to 1516 745 to 19   AAA   727/727
(100 %)
14 diff
(98.1 %id)
DA507843 brain SEC22B.e-u 801 to 1383 2 to 581   capped   580/580
(100 %)
7 diff
(98.8 %id)
BM681993 eye, fetal eye SEC22B.e-u 815 to 1516 716 to 19   AAA   698/698
(100 %)
10 diff
(98.6 %id)
BF688128 brain, glioblastoma SEC22B.e-u 824 to 1488 1 to 654       654/829
(78 %)
56 diff
(93.3 %id)
BP422593 small intestine SEC22B.e-u 844 to 1354 1 to 507     Submitted on the opposite strand 507/507
(100 %)
6 diff
(98.9 %id)
BQ006645 Chondrosarcoma, Left Pelvis SEC22B.e-u 861 to 1515 669 to 19   AAA   651/651
(100 %)
8 diff
(98.8 %id)
BM691747 eye, RPE and Choroid SEC22B.e-u 924 to 1403 21 to 503   tiling clone,   483/503
(96 %)
6 diff
(98.9 %id)
AA365799 pineal body SEC22B.e-u 936 to 1159 1 to 225   tiling clone,   225/225
(100 %)
3 diff
(98.7 %id)
CF541299 lung SEC22B.e-u 945 to 1516 590 to 19   AAA   572/572
(100 %)
7 diff
(98.8 %id)
AI024230   SEC22B.e-u 947 to 1517 571 to 3       569/574
(99 %)
0 diff
(100 %id)
AW959818   SEC22B.e-u 953 to 1515 1 to 563   tiling clone, AAA   563/563
(100 %)
3 diff
(99.5 %id)
DB354947 whole embryo, mainly head SEC22B.e-u 964 to 1516 549 to 1       549/550
(99 %)
15 diff
(97.3 %id)
BF207915 bladder, carcinoma, cell line SEC22B.e-u 984 to 1462 1 to 479       479/479
(100 %)
8 diff
(98.4 %id)
BF742805 breast SEC22B.e-u 993 to 1407 417 to 2     Submitted on the opposite strand 416/417
(99 %)
0 diff
(100 %id)
BU858769 mixed (pool of 40 RNAs) SEC22B.e-u 999 to 1515 1 to 517       517/529
(97 %)
5 diff
(99.1 %id)
AI582119 colon SEC22B.e-u 1011 to 1517 509 to 3       507/509
(99 %)
0 diff
(100 %id)
AI978980 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors SEC22B.e-u 1023 to 1516 510 to 16   AAA   495/495
(100 %)
4 diff
(99.2 %id)
FN071991 breast carcinoma SEC22B.e-u 1028 to 1100 1 to 72       72/73
(98 %)
2 diff
(97.3 %id)
DA658307.
matches multiple genes
  SEC22B.e-u 1035 to 1590 2 to 557   tiling clone, capped also hits gene nerporbo 556/556
(100 %)
3 diff
(99.5 %id)
FN132009 breast carcinoma SEC22B.e-u 1041 to 1150 109 to 1     Submitted on the opposite strand 109/110
(99 %)
3 diff
(97.3 %id)
AI523459 aorta SEC22B.e-u 1042 to 1516 475 to 1       475/475
(100 %)
3 diff
(99.4 %id)
BF221780 Prostate SEC22B.e-u 1061 to 1516 469 to 14   AAA   456/456
(100 %)
3 diff
(99.4 %id)
CR741863 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus SEC22B.e-u 1064 to 1516 467 to 15   AAA   453/453
(100 %)
3 diff
(99.4 %id)
FN096949 breast carcinoma SEC22B.e-u 1068 to 1187 123 to 5     Submitted on the opposite strand 119/123
(96 %)
0 diff
(100 %id)
AI493027 Kidney SEC22B.e-u 1070 to 1516 463 to 17   AAA   447/447
(100 %)
3 diff
(99.4 %id)
BF678528 Prostate SEC22B.e-u 1070 to 1695 1 to 626       626/826
(75 %)
26 diff
(96.9 %id)
AW006841 Kidney SEC22B.e-u 1076 to 1517 444 to 3       442/444
(99 %)
0 diff
(100 %id)
AA442691   SEC22B.e-u 1077 to 1429 1 to 353       353/353
(100 %)
2 diff
(99.5 %id)
DB564803 hypothalamus SEC22B.e-u 1081 to 1516 1 to 436   AAA Submitted on the opposite strand 436/436
(100 %)
4 diff
(99.1 %id)
FN113055 breast carcinoma SEC22B.e-u 1091 to 1184 1 to 91       91/92
(98 %)
4 diff
(95.7 %id)
AA814699 brain, substantia nigra SEC22B.e-u 1091 to 1516 440 to 16   AAA   425/425
(100 %)
6 diff
(98.6 %id)
AW663543 pooled SEC22B.e-u 1098 to 1516 435 to 17   AAA   419/419
(100 %)
4 diff
(99.1 %id)
AI674473 Prostate SEC22B.e-u 1099 to 1515 435 to 19   AAA   417/417
(100 %)
4 diff
(99.1 %id)
AA426156   SEC22B.e-u 1100 to 1515 416 to 2     Submitted on the opposite strand 415/416
(99 %)
0 diff
(100 %id)
AI253626 Prostate SEC22B.e-u 1108 to 1516 409 to 1       409/409
(100 %)
3 diff
(99.3 %id)
BQ015104 Chondrosarcoma, Left Pubic Bone SEC22B.e-u 1109 to 1516 426 to 19   AAA   408/408
(100 %)
4 diff
(99.1 %id)
AI935231 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) SEC22B.e-u 1118 to 1516 417 to 19   AAA   399/399
(100 %)
9 diff
(97.8 %id)
AA825476 germinal center B cell SEC22B.e-u 1119 to 1515 426 to 31   AAA   396/396
(100 %)
4 diff
(99.0 %id)
H99650 melanocyte SEC22B.e-u 1121 to 1517 398 to 1       398/408
(97 %)
9 diff
(97.8 %id)
FN157521 breast carcinoma SEC22B.e-u 1123 to 1233 107 to 1     Submitted on the opposite strand 107/107
(100 %)
0 diff
(100 %id)
AA846477 parathyroid gland, parathyroid tumor SEC22B.e-u 1137 to 1517 386 to 6       381/386
(98 %)
0 diff
(100 %id)
AI752847 bone marrow stroma SEC22B.e-u 1142 to 1515 392 to 19   tiling clone, AAA   374/374
(100 %)
3 diff
(99.2 %id)
AA782635 parathyroid gland, parathyroid tumor SEC22B.e-u 1148 to 1516 385 to 17   AAA   369/369
(100 %)
6 diff
(98.4 %id)
AI088977 pooled SEC22B.e-u 1154 to 1515 370 to 10       361/370
(97 %)
0 diff
(100 %id)
AI783526 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus SEC22B.e-u 1185 to 1517 334 to 2       333/334
(99 %)
0 diff
(100 %id)
BM874246   SEC22B.e-u 1192 to 1517 326 to 1       326/326
(100 %)
3 diff
(99.1 %id)
FN174629 breast carcinoma SEC22B.e-u 1246 to 1356 1 to 110       110/110
(100 %)
3 diff
(97.3 %id)
FN122489 breast carcinoma SEC22B.e-u 1250 to 1356 107 to 1     Submitted on the opposite strand 107/108
(99 %)
1 diff
(99.1 %id)
AA788634 parathyroid gland, parathyroid tumor SEC22B.e-u 1286 to 1516 246 to 18   AAA   229/229
(100 %)
4 diff
(98.3 %id)
AI627829 Kidney SEC22B.e-u 1291 to 1516 236 to 11   AAA   226/226
(100 %)
2 diff
(99.2 %id)
BQ232109 melanotic melanoma, skin SEC22B.e-u 1390 to 2276 1 to 891   tiling clone,   891/893
(99 %)
23 diff
(97.5 %id)
DB241340 trachea SEC22B.f-u 1 to 601 2 to 602 exact tiling clone, capped   601/601
(100 %)
3 diff
(99.6 %id)
AW392595 stomach SEC22B.g-u 1 to 415 8 to 422   tiling clone,   415/425
(97 %)
11 diff
(97.5 %id)
AW817847 stomach SEC22B.g-u 29 to 479 1 to 452   tiling clone,   452/452
(100 %)
22 diff
(95.2 %id)
AW382613 head_neck SEC22B.g-u 212 to 511 1 to 299 exact tiling clone,   299/300
(99 %)
6 diff
(98.0 %id)
BE153236 head_neck SEC22B.g-u 221 to 511 1 to 291 S20F tiling clone,   291/292
(99 %)
9 diff
(97.0 %id)
AW382661 head_neck SEC22B.g-u 227 to 494 28 to 294   tiling clone,   267/294
(90 %)
0 diff
(100 %id)
AW382597 head_neck SEC22B.g-u 228 to 511 1 to 284 exact     284/285
(99 %)
8 diff
(97.2 %id)
AV755676 bone marrow SEC22B.h 1 to 439 80 to 515 exact tiling clone,   436/446
(97 %)
4 diff
(99.2 %id)
AW363873 colon Gene SEC22B, variant not shown         Suspected internal deletion, this clone was ignored    
AW392584 stomach Gene SEC22B, variant not shown              
BC001364 Skin, melanotic melanoma. Gene SEC22B, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
AV737997 cord Blood Gene SEC22B, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BG180912 adenocarcinoma, cell line, Prostate Gene SEC22B, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e-u, .f-u, .g-u, .h Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI